Ramanuj graduated with a double Bachelor’s degree in Chemistry (B.Sc. Hons., University of Delhi, India, 1994), and in Genetics (B.A., Cambridge University, UK, 1996). He obtained his Ph.D. in Developmental Biology and Molecular Medicine from the University of Chicago, 2002.

Dr. DasGupta conducted his postdoctoral research at the Harvard Medical School, where he pioneered whole-genome high-throughput, RNAi-based functional genomic screens to identify novel regulators of cell-signalling pathways. In 2006, Dr. DasGupta established his own research laboratory at the NYU-Cancer Institute, where he served as an Associate Professor till 2014. Thereafter, he moved to the Genome Institute of Singapore (GIS) where as a Senior Group Leader he led a program in Precision Oncology and Cancer Evolution.

More recently, Dr. DasGupta has taken up the position of Professor of Cancer Systems Biology at the School of Cancer Sciences, University of Glasgow and the CRUK Scotland Institute. The major focus of his program is to interrogate the mechanistic basis for how inflammatory ecosystems lead to the progression of early-stage chronic disease to cancer. The DasGupta laboratory utilises a variety of single cell and spatial multi-omic approaches to define the mechanistic basis for spatio-temporal cross-regulatory interactions between pathogenic cells and their microenvironment that drive cellular plasticity and phenotypic heterogeneity, both during tumorigenesis and tumour progression in etiologically distinct solid cancers.